Founded in September 2000, it specializes in model organisms and is dedicated to gene editing and life decoding.
It provides customized solutions such as genetically engineered animal models, phenotype analysis and high-throughput screenings to advance life science research and drug discovery. It owns a rapidly-growing repository of Research-Ready models , including immunodeficient and humanized mouse models to advance R&D for cancer immunotherapy.